Comparison of in vitro and in vivo α/β ratios for prostate cancer

Physics in Medicine and Biology

Volumn 49, Issue 19, 2004, Pages 4477-4491

  Carlson, David J ^a   Stewart, Robert D ^a   Li, X Allen ^b,e   Jennings, Kristofer ^c   Wang, Jian Z ^d,e   Guerrero, M ^e  

^a PURDUE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c PURDUE UNIVERSITY   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CELLS; PARAMETER ESTIMATION; RADIOACTIVATION ANALYSIS;

PROSTRATE CANCER; RADIOSENSITIVITY;

TUMORS;

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIOSENSITIVITY;

ALPHA PARTICLES; BETA RAYS; CELL SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; RELATIVE BIOLOGICAL EFFECTIVENESS; TUMOR CELLS, CULTURED;

EID: 5744247185     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/49/19/003     Document Type: Article

References (53)

1. Algan O et al 1996 Radiation inactivation of human prostate cancer cells: the role of apoptosis Radiat. Res. 146 267-75
2. Begg A C et al 1993 Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy Int. J. Radiat. Biol. 64 393-405
3. Brenner D J 1992 Correlations between alpha/beta and T1/2: implications for clinical biological modelling Br. J. Radiol. 65 1051-4
4. Brenner D J and Hall E J 1999 Fractionation and protraction for radiotherapy of prostate carcinoma Int. J. Radiat. Oncol. Biol. Phys. 43 1095-101
5. Brenner D J et al 1998 The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships Radiat. Res. 150 83-91
6. Brenner D J et al 2002 Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue Int. J. Radiat. Oncol. Biol. Phys. 52 6-13
7. Brock W A et al 1995 Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer Int. J. Radiat. Oncol. Biol. Phys. 32 1371-9
8. Burnet N G et al 1994 The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules Radiother. Oncol. 33 228-38
9. Carlone M et al 2003a Clinical radiobiology, early and late responding tissues, and hypofractionation for prostate cancer Can. Med. Phys. News 49 56-62
10. Carlone M et al 2003b Comparison of α/β estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer Med. Phys. 30 2832-48
11. Chapman J D 2003 Single-hit mechanism of tumour cell killing by radiation Int. J. Radiat. Biol. 79 71-81
12. Curtis S B 1986 Lethal and potentially lethal lesions induced by radiation - a unified repair model Radiat. Res. 106 252-70
13. Deweese T L et al 1998 Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure J. Urol. 159 591-8
14. D'Souza W D, Thames H D and Kuban D A 2004 Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability Int. J. Radiat. Oncol. Biol. Phys. 58 1540-8
15. Efron B 1979 Bootstrap methods: another look at the jackknife Ann. Stat. 7 1-26
16. Forman J D et al 1996 Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study Int. J. Radiat. Oncol. Biol. Phys. 34 655-62
17. Fowler J F, Chappell R J and Ritter M A 2001 Is α/β for prostate tumors really low? Int. J. Radiat. Oncol. Biol. Phys. 50 1021-31
18. Freedman G M et al 1996 Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation Int. J. Radiat. Oncol. Biol. Phys. 35 407-9
19. Geara F B et al 1993 Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients Int. J. Radiat. Oncol. Biol. Phys. 27 1173-9
20. Guerrero M et al 2002 Equivalence of the linear-quadratic and two-lesion kinetic models Phys. Med. Biol. 47 3197-209
21. Haikonen J et al 2003 Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual? Int. J. Cancer 103 784-8
22. Hanks G E et al 1997 Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study Int. J. Radiat. Oncol. Biol. Phys. 37 543-50
23. Hlatky L et al 2002 Radiation-induced chromosome aberrations: insights gained from biophysical modeling BioEssays 24 714-23
24. Johansen J et al 1994 Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy Int. J. Radiat. Biol. 66 407-12
25. Johansen J et al 1996 Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy Radiother. Oncol. 40 101-9
26. Kal H B and Van Gellekom M P 2003 How low is the α/β for prostate cancer? Int. J. Radiat. Oncol. Biol. Phys. 57 1116-21
27. Kampinga H H et al 1997 Correlation between slowly repairable double-strand breaks and thermal radiosensitization in the human HeLa S3 cell line Int. J. Radiat. Biol. 72 293-301
28. Leibel S A et al 1994 Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study Int. J. Radiat. Oncol. Biol. Phys. 28 55-65
29. Leith J T et al 1993 Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: x-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo Int. J. Radiat. Oncol. Biol. Phys. 25 283-7
30. Lindsay P E et al 2003 The influence of brachytherapy dose heterogeneity on estimates of α/β for prostate cancer Phys. Med. Biol. 48 507-22
31. Malaise E P et al 1986 Distribution a radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data Int. J. Radiat. Oncol. Biol. Phys. 12 617-24
32. Mariano Ruiz de Almodovar J et al 2002 Individualization of radiotherapy in breast cancer patients: possible usefulness of a DNA damage assay to measure normal cell radiosensitivity Radiother. Oncol. 62 327-33
33. Millar W T et al 1996 Repair kinetics in pig epidermis: an analysis based on two separate rates of repair Int. J. Radiat. Biol. 69 123-40
34. Nahum A E et al 2003 Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the α/β ratio Int. J. Radiat. Oncol. Biol. Phys. 57 391-401
35. Nelson J M et al 1990 Multiple components of split-dose repair in plateau-phase mammalian cells: a new challenge for phenomenological modelers Radiat. Res. 121 154-60
36. Oppitz U et al 2001 The in vitro colony assay: a predictor of clinical outcome Int. J. Radiat. Biol. 77 105-10
37. Peacock J H, Eady J J, Edwards S M, McMillan T J and Steel G G 1992 The intrinsic alpha/beta ratio for human tumour cells: is it a constant? Int. J. Radiat. Biol. 61 479-87
38. Press W H et al 1992 Numerical Recipes in FORTRAN: The Art of Scientific Computing 2nd edn (New York: Cambridge University Press)
39. Roberts S A and Hendry J H 1998 A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity Int. J. Radiat. Oncol. Biol. Phys. 41 689-99
40. Rudat V et al 1997 In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer Radiother. Oncol. 43 181-8
41. Sachs R K and Brenner D J 1998 The mechanistic basis of the linear-quadratic formalism Med. Phys. 25 2071-3
42. Sachs R K, Hahnfeld P and Brenner D J 1997 The link between low-LET dose-response and the underlying kinetic of damage production/repair misrepair Int. J. Radiat. Biol. 72 351-74
43. Steel G G et al 1987 The dose-rate effect in human tumor cells Radiother. Oncol. 9 299-310
44. Stewart R D 2001 Two-lesion kinetic model of DSB rejoining and cell killing Radiat. Res. 156 365-78
45. Stock R G et al 1988 A dose-response study for 1251 prostate implants Int. J. Radiat. Oncol. Biol. Phys. 41 101-8
46. Thames H D et al 1990 Time-dose factors in radiotherapy: a review of the human data Radiother. Oncol. 19 219-35
47. Tobias C A 1985 The repair-misrepair model in radiobiology: comparison to other models Radiat. Res. Suppl. 8 S77-95
48. Van Rongen E, Thames H D and Travis E L 1993 Recovery from radiation damage in mouse lung: interpretation of two rates of repair Radiat. Res. 133 225-33
49. Wang J Z and Li X A 2003 Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose Med. Phys. 30 34-40
50. Wang J Z, Guerrero M and Li X A 2003a How low is the α/β ratio for prostate cancer? Int. J. Radiat. Oncol. Biol. Phys. 55 194-203
51. Wang J Z, Guerrero M and Li X A 2003b Low α/β ratio for prostate cancer: in response to Dr. Fowler et al Int. J. Radiat. Oncol. Biol. Phys. 57 595-6
52. Wang J Z et al 2003c The low α/β ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us? Int. J. Radiat. Oncol. Biol. Phys. 57 1101-8
53. Wang J Z et al 2003d Impacts of prolonged dose-delivery time on tumor control: a note of caution for IMRT Int. J. Radiat. Oncol. Biol. Phys. 57 543-52